TP53 and mismatch repair cancer syndrome 1: Based on sequencing and immunohistochemical results, ProMisE includes mismatch repair deficiency (MMRd), DNA polymerase epsilon (POLE) mutations, wild-type p53, and abnormal p53 as molecular markers.